Ancient Grains Linked to Improved Type 2 Diabetes Outcomes

Health & Lifestyle
278

Translate to Spanish or other 102 languages!

A new study suggests ancient grains like oats and buckwheat may help manage blood sugar and cholesterol in type 2 diabetes. Image for illustration purposes
A new study suggests ancient grains like oats and buckwheat may help manage blood sugar and cholesterol in type 2 diabetes. Image for illustration purposes

Medical New Today

- Advertisement -
  • A new study suggests ancient grain consumption is associated with improved health outcomes for people with type 2 diabetes. 
  • Ancient grains like oats are rich in dietary fiber and phytochemicals that may help manage blood sugar and cholesterol. 
  • Experts recommend incorporating minimally refined grains into a healthy, balanced diet to reap the most benefits.

A new study highlights the potential benefits of including ancient grains in dietary patterns for people with diabetes.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/ancient-grains-may-help-treat-type-2-diabetes?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-05-06&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Some Action on a Pickleball Court Can be Fun & Safe, Even With a Heart Condition
Next article
Early Care and Education Providers – on the Frontlines of Public Health

More Articles

Small Steps in Weight Loss Lead to Big Heart Health Benefits

When people think about weight loss, they often picture dramatic transformations: a major drop on the scale, a new clothing size or a before-and-after photo. But when it comes to overall health, some of the biggest benefits can begin long before those milestone moments.

FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer  

The U.S. Food and Drug Administration expanded the approved use of Anktiva (nogapendekin alfa inbakicept-pmln), given with Bacillus Calmette-Guérin (BCG), to include adults with high-grade papillary-only bladder cancer that has not spread into the bladder muscle and has not responded to BCG treatment.

The Power of Proper Handwashing

One simple habit can go a long way toward helping you stay healthy.

Speak Up, Reach Out: STHS Behavioral Tackles Suicide Prevention

Not all wounds are visible. Every day, people struggle with emotional pain, depression and feelings of hopelessness that may go unnoticed by those around them.
- Advertisement -